Dr. Rob de Jong

March 28, 2023

Dr. Rob de Jong

All-round researcher at Hybridize. Worked for 12 years in the LUMC as research technician and PhD student. Studied the role of inflammation in cardiac and vascular remodelling, including the potential therapeutic effect of gene silencing oligo’s, and worked on the identification of neoantigen specific peptides as possible therapeutic targets against AML.